GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: STI-1558 | STI1558
Compound class:
Synthetic organic
Comment: Olgotrelvir (STI-1558) is a novel antiviral prodrug compound that is active as a dual inhibitor of viral and host proteases [2]. The active form is called AC1115. Mechanistically olgotrelvir inhibits SARS-CoV-2 3CL protease (Mpro) and human cathepsin L. It disrupts both viral entry (host protease dependent) and replication (Mpro dependent) and was developed as a potential treatment for COVID-19.
|
|
References |
1. Jiang R, Han B, Xu W, Zhang X, Peng C, Dang Q, Sun W, Lin L, Lin Y, Fan L et al.. (2024)
Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19. NEJM Evid, 3 (6): EVIDoa2400026. [PMID:38804790] |
2. Mao L, Shaabani N, Zhang X, Jin C, Xu W, Argent C, Kushnareva Y, Powers C, Stegman K, Liu J et al.. (2024)
Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19. Med, 5 (1): 42-61.e23. [PMID:38181791] |